👀 Chenrui Li

🔍 Search 📋 Browse 🏷 Tags ❀ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
3991
Articles
2551
Name variants
Also published as: Xiaocun Li, Jianyu Li, Xinzhi Li, Guanqiao Li, Zequn Li, Guang-Xi Li, Yubo Li, Bugao Li, Qingchao Li, Xikun Li, Hong-Tao Li, Guobin Li, Xihao Li, Rongqing Li, Chang-Da Li, Meng-Yue Li, DaZhuang Li, Shunqin Li, Jiajie Li, Yaqiong Li, Yuan-hao Li, Yongmei Li, X Y Li, Peilin Li, Ran Li, Chunshan Li, Yixiang Li, Guanglve Li, Ye Li, Zili Li, Yihao Li, Qing Run Li, Liling Li, Meng-Yang Li, Ziyun Li, Jun-Ying Li, Xinhai Li, Yongjiang Li, Wanru Li, Wenhao Li, Shisheng Li, Sai Li, Guangwen Li, Hua Li, Dongmei Li, Jiayang Li, Zunjiang Li, Minglong Li, Wenzhe Li, Zihan Li, Jin-Long Li, Hongxin Li, Caiyu Li, Fa-Hui Li, Guangpu Li, Teng Li, Wen-Jie Li, Hegen Li, Ang Li, Zhizong Li, Lu-Yun Li, Peng Li, Shiyu Li, Fang Li, Jiuke Li, Miyang Li, Mingxu Li, Chen-Xi Li, Panlong Li, Changwei Li, Biyu Li, Yaoqi Li, San-Feng Li, Jiaming Li, Jiyuan Li, Rongkai Li, Yani Li, Linke Li, C Y Li, Thomas Li, Siting Li, Yongnan Li, Jinchen Li, Jin-Ping Li, Xuewen Li, R Li, Xianlong Li, Aixin Li, Xuening Li, Guang Li, Xiaoming Li, Z-H Li, Yongli Li, Baohong Li, Shuyuan Li, L Li, Yuanmei Li, Yanwu Li, Hualing Li, Sibing Li, Xining Li, Qinghe Li, Zonghua Li, Liqin Li, Jingya Li, Youjun Li, Zheng-Dao Li, Zhenshu Li, Heng-Zhen Li, Yuhui Li, Wen-Ying Li, Wei Li, Shuanglong Li, Fei-feng Li, Letai Li, Kangli Li, Ming Li, Wenbo Li, Runwen Li, Yarong Li, Weidong Li, S E Li, Xin-Tao Li, Ruotong Li, Shuguang Li, Xiuzhen Li, Lingxi Li, Chuan-Hai Li, Tingting Li, Guanghua Li, Zhongyu Li, Zhen-Yu Li, Deyu Li, Hansen Li, Jinzhi Li, Yijing Li, Kaifeng Li, Wen-Xing Li, Qintong Li, Naishi Li, Xin-Ping Li, Han-Ni Li, Jiaying Li, Cui-lan Li, Ruonan Li, Jun-Jie Li, Shuhao Li, Ruitong Li, Suyan Li, Gen-Lin Li, Dianjie Li, Junhui Li, Ya-Jun Li, Xue Cheng Li, Ding-Biao Li, Xiying Li, Yansong Li, Weiyong Li, Xinyang Li, Cui Li, Xiaoyong Li, Y L Li, Xueyi Li, Jingxiang Li, Wenxue Li, Jianglin Li, Yingpu Li, Yan-Hua Li, Jing-Yao Li, Shawn Shun-Cheng Li, Xiao-Min Li, Wan Jie Li, Ya-Ting Li, Dongbiao Li, Keguo Li, Yuanfei Li, Longhui Li, Jing-Yi Li, Zhonghua Li, Chunyi Li, Peiyun Li, Qinglan Li, Yue-Ting Li, Da Li, YiPing Li, Demin Li, Haipeng Li, Chuan Li, Ze-An Li, Jianmin Li, Minhui Li, Yu Li, Yiwei Li, Xiangzhe Li, Minglun Li, Xue-Min Li, Kenneth Kai Wang Li, Chunlan Li, Chiyang Li, Hulun Li, Juan-Juan Li, Hua-Zhong Li, Jiaomei Li, Xiangyun Li, Jing Li, Yingshuo Li, Baixing Li, Dengke Li, Qingling Li, Rui-Han Li, Dong Li, Xiaoxia Li, Dezhi Li, Sheng-Jie Li, Ying-Qing Li, Xin-Jian Li, Guangxi Li, Yanhui Li, Sha-Sha Li, Mengxuan Li, Ziyu Li, Gang Li, Panyuan Li, Hong-Wen Li, Xiaojuan Li, Dongnan Li, Huaiyuan Li, Ji-Liang Li, Huaping Li, C H Li, Bohua Li, Pei-Ying Li, Shaobin Li, Ronald Li, Shilun Li, Shi-Hong Li, John Zhong Li, Xinyu Li, Lujiao Li, Song-Chao Li, Chenghong Li, Baohua Li, Nianfu Li, Jun-Cheng Li, Yimeng Li, Chunting Li, Chien-Feng Li, Mei-Zhen Li, Zhengjie Li, Liwei Li, Yan-Yan Li, Huijun Li, Chengyun Li, Lijun Li, Hening Li, Fengxia Li, Jialing Li, Xin Li, Ningyan Li, Zhenghui Li, Ailing Li, Chaochen Li, Tengyan Li, Xianlu Li, Jiaqi Li, Jiabei Li, Wenjing Li, Jingshu Li, Han-Bo Li, Zengyang Li, Chunyan Li, Runzhen Li, Xi-Hai Li, Xuezhong Li, MengGe Li, Pei-Lin Li, Wan-Xin Li, Ruobing Li, Ning Li, Meitao Li, Xia Li, Ziqiang Li, Wen-Xi Li, Shenghao Li, Hehua Li, Yucheng Li, Dujuan Li, Yuying Li, Shaofei Li, Shaoguang Li, Min-Rui Li, Shuqiang Li, Dan C Li, Huashun Li, Ganggang Li, Haoqi Li, Handong Li, Yan-Nan Li, Xianglong Li, Jing-Jing Li, Songhan Li, Conglin Li, Qingli Li, Miao Li, Chenyu Li, Ke Li, Zhen-Hua Li, Chuan-Yun Li, Gaoyuan Li, Youming Li, Qingrun Li, Dong-Yun Li, Shuangfei Li, Fengfeng Li, Qinggang Li, Huixia Li, Xingye Li, Xiangjun Li, Huiying Li, Xingyu Li, Zhaoping Li, Wenying Li, Honghui Li, Cheung Li, Xuelian Li, Zhenming Li, Changyan Li, Mulin Jun Li, Shangjia Li, Jingjing Li, Suhong Li, Xinping Li, Siyu Li, Guangzhen Li, Xiangyan Li, Shiyun Li, Xiaoyu Li, Yaobo Li, Xuewang Li, Mei Li, Manjiang Li, Wan Li, Xiao-Li Li, Xiaoya Li, Shan Li, Shitao Li, Zehan Li, Lijia Li, Huiliang Li, Chunqiong Li, Junjun Li, Hui-Long Li, Zhao-Cong Li, Zhi-Wei Li, Wenxi Li, Chang-hai Li, Yuqiu Li, Xue-Yan Li, Yuan-Yuan Li, Xiang-Jun Li, Chia Li, Y X Li, Yunyun Li, Zhen-Jia Li, Qiuxuan Li, De-Jun Li, Keqing Li, Junxian Li, Shuwen Li, Lingjun Li, Deheng Li, Si-Xing Li, Yaodong Li, Shigang Li, Gao-Fei Li, Minle Li, Le-Le Li, Ziwen Li, Yongqiu Li, Pu-Yu Li, Nan-Nan Li, Lan-Lan Li, Hongming Li, Shuang Li, Wanting Li, Gong-Hua Li, Zhengyu Li, Weiguang Li, Guoqing Li, Xiaomeng Li, Yuanze Li, Yunqi Li, Yuandong Li, Changcheng Li, Shiyue Li, Hanbo Li, Yinggao Li, Dingshan Li, Linlin Li, Jin-Wei Li, Cheng-Tian Li, Yaxi Li, Wei-Ming Li, Ming-Han Li, Wenchao Li, Guangyan Li, Zhaosha Li, Xuesong Li, Chun-Quan Li, Yongzhen Li, Tao Li, Xiankai Li, Yaxuan Li, Tian-wang Li, Yuchan Li, Jiaxi Li, Yalin Li, Pei-Zhi Li, Guanyu Li, Jinlan Li, Huizi Li, Jianping Li, Yun-Lin Li, Yadong Li, Sujing Li, Wenzhuo Li, Xuri Li, Mengqiu Li, Yun Li, Ling-Ling Li, Chengwen Li, Shu-Feng Li, Haojing Li, Zhiyu Li, Ziyang Li, Yaochen Li, Qian Li, Bohao Li, Wenyang Li, Wenming Li, Mingxuan Li, Bingsong Li, Anqi Li, Shuai Li, Xiaoju Li, Na Li, Huibo Li, Chuanfang Li, Pengsong Li, Ruotian Li, Chunya Li, En-Min Li, Zong-Xue Li, Yan Ning Li, Honglin Li, Min-jun Li, Jinhua Li, Qian-Qian Li, Yuanheng Li, Chunxiao Li, Shijun Li, Kuan Li, Baoguang Li, Jie-Shou Li, Zimeng Li, Mengmeng Li, W-B Li, Binkui Li, Yu-Sheng Li, Junjie Li, Xiaoqi Li, Xiucui Li, Haihua Li, Yu-Lin Li, Tsai-Kun Li, Shujing Li, Mengyun Li, Mingna Li, Lanlan Li, Moyi Li, Xiyun Li, Ya-Pei Li, Zhongjie Li, Zhenbei Li, Shuangshuang Li, Hongwei Li, Ding-Jian Li, Xiao-Qiang Li, Danni Li, Min Li, Pengyang Li, Kun-Xin Li, Xiangpan Li, Zesong Li, Mingfei Li, Shuwei Li, Mingdan Li, Xihe Li, Jianfeng Li, Dexiong Li, Rongsong Li, Yinxiong Li, Hong-Yu Li, Weijian Li, Changhui Li, Dechao Li, Wenxia Li, Guoxiang Li, Ziru Li, Juxue Li, Man Li, Huayin Li, Xiao-yu Li, Jianyi Li, Guowei Li, Xingya Li, Gongda Li, Yajun Li, Wei-Ping Li, Nanjun Li, P H Li, Ranran Li, Suping Li, Jason Li, Monica M Li, Xianlun Li, Qi Li, Xiaoli Li, Xionghui Li, Fei Li, Hongmei Li, Xu-Wei Li, Mengsen Li, Quanpeng Li, Yajiao Li, Qilan Li, Qiuhong Li, Zongyun Li, Xiao-Yun Li, Cheng-Lin Li, Yousheng Li, Wen-Ting Li, Guoping Li, A Li, Simin Li, Weiguo Li, Xue-Nan Li, Xiaoying Li, Shengsheng Li, Hong Li, Yuqi Li, Zihua Li, Qing Li, Jiaping Li, Weiyang Li, Feng Li, Peihong Li, Jin-Mei Li, Lisha Li, Cuicui Li, Kaibo Li, Hanbing Li, Meng-Hua Li, J T Li, Xiangwei Li, Baiqiang Li, Ziliang Li, Donghe Li, Zheng Li, Congfa Li, Wenrui Li, Yong Li, Xiuling Li, Jingqi Li, Zhiyong Li, Xiao-Kang Li, Hanqi Li, Yangyang Li, Dongfang Li, Zhuorong Li, X-H Li, Dong Sheng Li, Lan-Juan Li, Xianrui Li, Zhigao Li, Chenlin Li, Zihui Li, Guoli Li, Huanqiu Li, Zhan Li, Weisong Li, Xinglong Li, Xiaozhen Li, Zhiyang Li, Cunxi Li, Ying Li, Jianlin Li, Yanshu Li, Guiying Li, Jinku Li, Cuiling Li, Zhisheng Li, Changgui Li, Xuekun Li, Yuguang Li, Wenke Li, Jiayi Li, Suwen Li, Peihua Li, Chang-Ping Li, Guangda Li, Jieming Li, Chunhui Li, Tongyao Li, Peiyu Li, Linfeng Li, Yuzhe Li, Qifang Li, Chang-Yan Li, Xiaolin Li, Duanxiang Li, Vivian Li, Justin Li, Meiting Li, Xue-Er Li, Hongchang Li, Youwei Li, Ronggui Li, Xingwang Li, Tiange Li, Yongjia Li, Dacheng Li, Xinmin Li, Luquan Li, Guoxing Li, Jianyong Li, Zongchao Li, Jia Li, Haimin Li, Sheng-Qing Li, Lingjie Li, Yiwen Li, Baoqi Li, Leyao Li, Xiao-Qin Li, Jiajing Li, Yanlin Li, Liao-Yuan Li, Yongkai Li, Hangwen Li, Hengguo Li, An-Qi Li, Xuehua Li, AnHai Li, Chenli Li, Zhengrui Li, Rumei Li, Yan-Yu Li, Lipeng Li, Qinqin Li, Qinghua Li, Leilei Li, Lianyong Li, Zhou Li, Q Li, Bizhi Li, Cheng-Wei Li, Wenwen Li, Jian'an Li, Guangqiang Li, Sichong Li, Wenyi Li, Qing-Min Li, Meiyan Li, Yun-Da Li, Jian-Qiang Li, Yingrui Li, Chenfeng Li, Shen Li, Ziqi Li, Yunfeng Li, Shufen Li, Yueqi Li, Xiao-Guang Li, Jiali Li, Zhencheng Li, Qiufeng Li, Pinghua Li, Xu Li, Zhenli Li, Yunxiao Li, Rosa J W Li, Hsin-Yun Li, XiaoQiu Li, Zhankui Li, Zhi Li, Zhijie Li, Huimin Li, Ruifang Li, Xiao-xu Li, Man-Xiang Li, Cong Li, Chengbin Li, Yuping Li, G Li, Zhi-Yong Li, Yukun Li, Xiong Bing Li, Wen Lan Li, Qingjie Li, Han Li, Yutang Li, Hankun Li, Hongling Li, Zhifan Li, Yan-Guang Li, Ji-Min Li, Peipei Li, Tian-Yi Li, Zhihao Li, Yao Li, Zheyun Li, Zhonglin Li, Lin Li, Jinfang Li, Chenjie Li, Yanming Li, S L Li, Ben-Shang Li, Hong-Lan Li, Xionghao Li, Shunqing Li, Ming-Kai Li, Lan Li, Yanwei Li, Chien-Te Li, Wenyan Li, Xiaoheng Li, Zeyuan Li, Hongqin Li, Zhenhao Li, Jonathan Z Li, Yong-Liang Li, M Li, Jiehan Li, Hongguo Li, Chenxin Li, Yongsen Li, Qingyun Li, Pengyu Li, Ai-Qin Li, Zichao Li, Cien Li, Qingyu Li, Xijing Li, Jingshang Li, Xingyuan Li, Dehua Li, Yanjiao Li, Jia-Huan Li, Guoxi Li, Xudong Li, Xingfang Li, Jisheng Li, Rongyao Li, Ru Li, Jiangya Li, Yiche Li, Yilang Li, Yunshen Li, Jingchun Li, Hexin Li, H J Li, Yanping Li, Qing-Wei Li, Qiang Li, Hsiao-Hui Li, L I Li, Hongzheng Li, Laiqing Li, Ningyang Li, Zhongxia Li, Guangquan Li, Shun Li, Hui-Jun Li, Xuefei Li, Guojun Li, Hung Li, Senlin Li, Jinping Li, Sainan Li, Jinghui Li, Zulong Li, Chengsi Li, P Li, Fulun Li, Yonghao Li, Mingli Li, Yehong Li, Pei Li, Quanshun Li, Yongping Li, Liguo Li, Weimin Li, Mingxia Li, Xue-Hua Li, M V Li, Gan Li, Shichao Li, Dapei Li, Zejian Li, Lihong Li, Haixia Li, Jingmei Li, Ao Li, Yitong Li, Siwen Li, Yanlong Li, Zhao Li, Kui Li, Yunxu Li, Xuanfei Li, Zilin Li, Mingqiang Li, Xiaojiao Li, Yinzhen Li, Yunsheng Li, Li-Min Li, Xiangqi Li, Jia-Peng Li, Wenqi Li, Haibo Li, Xiao-Jun Li, Yan-Hong Li, Shi Li, Xueling Li, Conghui Li, Xiaoxiong Li, Wanni Li, Chitao Li, Haiyang Li, Xiaobai Li, Pingping Li, Mingquan Li, Suran Li, Yuanfang Li, Yingqin Li, Qiner Li, Jiafang Li, Shanhang Li, Han-Bing Li, Zongzhe Li, Yikang Li, Si-Yuan Li, Hongmin Li, Caihong Li, Yajing Li, Benyi Li, Yuquan Li, Hongzhi Li, Chengxin Li, Xiaojiaoyang Li, Xinxin Li, Jian-Shuang Li, Yubin Li, Dazhi Li, Chenglan Li, Yuhong Li, Fengqiao Li, Di Li, Yanbing Li, Jufang Li, Zecai Li, Qipei Li, Xiaoning Li, Xiyue Li, Minghua Li, Tianchang Li, Zhuoran Li, Hongru Li, Shiqi Li, Mei-Ya Li, Wuyan Li, Yi-Ling Li, Yingjian Li, Zhirong Li, Wang Li, Mingyang Li, Weijun Li, Boyang Li, Cai Li, Jingcheng Li, Ivan Li, Mengshi Li, Manxia Li, Ya Li, Dan-Ni Li, Wen-Chao Li, Sunan Li, Zhencong Li, Lai K Li, Jiong Li, Daiyue Li, Bingong Li, Chunxue Li, Yunlong Li, Jianshuang Li, Juanling Li, Xinbin Li, Xue-jing Li, Yuling Li, Yetian Li, Xianlin Li, Chuangpeng Li, Mingrui Li, Yanjun Li, Jiequn Li, Zhongding Li, Jiangui Li, Zhengyang Li, Cyril Li, Xinghui Li, Yuefei Li, Xinyan Li, Xiaoyun Li, Yushan Li, Ping'an Li, Weiping Li, Huan Li, Changjiang Li, Chengping Li, He-Zhen Li, G-P Li, Yinliang Li, Wen Li, Weihai Li, Yu-Kun Li, Jiangan Li, Zhaojin Li, Bingxin Li, Wenjuan Li, Chia-Yang Li, Wenyu Li, Hairong Li, Su Li, Mei-Lan Li, Wenjun Li, Jiaxin Li, Chenguang Li, Ming D Li, Ruyue Li, Xiaolian Li, Ya-Ge Li, Yinyan Li, Guangli Li, Rujia Li, Qijun Li, Lixia Li, Yunrui Li, Yuhuang Li, Shanshan Li, Wan-Shan Li, Jing-gao Li, Yiyang Li, Fengxiang Li, Nana Li, Jingui Li, Huamao Li, Xiankun Li, Jingke Li, Tianyao Li, Xiaowei Li, Junming Li, Hai-Yun Li, Zhongxian Li, H-J Li, Zhixiong Li, Lingyan Li, Xuhang Li, Chen-Lu Li, Jialun Li, Xinjian Li, Zilu Li, Sheng-Fu Li, Zezhi Li, Xue-Fei Li, Yudong Li, Hongjiang Li, Jingyun Li, Binghua Li, Hanjun Li, Qihua Li, Jin-Qiu Li, Jiaxuan Li, Guangjin Li, Xutong Li, Ranwei Li, Kai Li, Wei-Li Li, Keanning Li, Ling Li, Peiqin Li, Xiaodong Li, Nanxing Li, Qihang Li, Baoguo Li, Jianrong Li, Zhehui Li, Chenghao Li, Weike Li, Chuanbao Li, Zhixuan Li, Chuzhong Li, M D Li, Yuan-Tao Li, Kening Li, Guilan Li, Wanshi Li, Ling-Zhi Li, Hengtong Li, Yifan Li, Ya-Li Li, Songyun Li, Xiaoran Li, Bolun Li, Linchuan Li, Jiachen Li, Haibin Li, Huangbao Li, Guo-Chun Li, Xinli Li, S Li, Wenqing Li, Wenhua Li, Caiyun Li, Xinrui Li, Hanbin Li, Wanwan Li, Jia Li Li, Wan-Hong Li, Mingke Li, Huanhuan Li, Xiaoyuan Li, Zongfang Li, Yang Li, BoWen Li, Duoyun Li, Yimei Li, Zhi-qiang Li, Yi-Ting Li, Jiangxia Li, Yujie Li, Zhiping Li, Yan-Li Li, Haiming Li, Gaijie Li, Yuemei Li, Xuefeng Li, Xiao-Hong Li, Mengjuan Li, Yinglin Li, Yaofu Li, Ren-Ke Li, Yi Li, Baosheng Li, Mian Li, Yujun Li, Lixi Li, Jin-Xiu Li, Jiwen Li, Zhouhua Li, Qingqin S Li, Honglei Li, Guojin Li, Xin-Yue Li, Dingchen Li, Xiaoling Li, Meng-Jun Li, Peining Li, Congjiao Li, Huilin Li, Songtao Li, Fusheng Li, Dai Li, Meiyue Li, Kechun Li, Keshen Li, Yuxin Li, Shaoliang Li, Shu-Xin Li, Hong-Zheng Li, Tianye Li, Qun Li, Zhen Li, Mengling Li, Jia-Da Li, Baoqing Li, Pu Li, Xingli Li, Bingkun Li, Nien-Chi Li, Tiewei Li, Daniel Tian Li, Rong-Bing Li, Wei-Yang Li, Rong Li, Mingkun Li, Binxing Li, Zixiao Li, Guixin Li, Quanzhang Li, Da-wei Li, Xiumei Li, Melody M H Li, Peibo Li, Huanjun Li, Chung-Hao Li, Liuzheng Li, Zhanjun Li, Yifei Li, Tianming Li, Chang-Sheng Li, Tianyou Li, Jipeng Li, Longxuan Li, Shi-Guang Li, Wenxiu Li, Zhuang Li, Yu-Hao Li, Shilin Li, Shili Li, Meiqing Li, Hengyu Li, Yinhao Li, Junying Li, Mufan Li, Chun-Lai Li, Shiya Li, Xiao-Jiao Li, Li Li, Hanxue Li, Lulu Li, L P Li, Xiaoqin Li, Chunmei Li, Mingjun Li, Yuanhua Li, Qiaolian Li, Ji-Cheng Li, Haolong Li, Xuanzheng Li, Peng-li Li, Quan Li, Xue-Ying Li, Yongzhe Li, Tianyi Li, Qingfeng Li, Nanlong Li, Ping Li, Fangzhou Li, Nien-Chen Li, Yuanchuang Li, Haiying Li, Yunting Li, Hong-Yan Li, Shengbiao Li, Yue-Rui Li, Ruidong Li, Y M Li, Sijie Li, Meilan Li, D C Li, Andrew C Li, Jianye Li, Qiuyan Li, Tingguang Li, Xiangyang Li, Chunjie Li, Tianfeng Li, Anna Fen-Yau Li, Minghui Li, Jiangfeng Li, Jie-Pin Li, Kaiyi Li, Junyi Li, Dongtao Li, Fengyuan Li, Chenxi Li, Zuo-Lin Li, Zhengwei Li, Yan-Chun Li, Suiyan Li, Qiaoqiao Li, Xiaotian Li, Zhenguang Li, Jia-Ru Li, Pei-Qin Li, Chun-Xiao Li, Shu-Hong Li, Shuyue Li, Quan-Zhong Li, Tongzheng Li, Fangyan Li, Duo Li, Ren Li, Hongye Li, Lanfang Li, Mingwei Li, Wenxin Li, W J Li, Zhijia Li, Jingtong Li, Lucy Li, Zhengpeng Li, Xiayu Li, Baolin Li, Cuilan Li, Yuting Li, Xiaobo Li, Meijia Li, Shujiao Li, Kun-Ping Li, Weirong Li, Weihua Li, Runzhao Li, Xiang-Dong Li, Yanxin Li, Xiufeng Li, Yingjun Li, Xiaohuan Li, Ying-Qin Li, Fan Li, Jun Z Li, Yiheng Li, Taiwen Li, Xiaorong Li, Haifeng Li, Liping Li, Rena Li, Jiangtao Li, Yu-Jui Li, Rui-Jún Eveline Li, Xuanxuan Li, Bing-Mei Li, Yunman Li, Shuhua Li, Chunying Li, Leipeng Li, Weiheng Li, Baizhou Li, Han-Ru Li, Sheng Li, Yaqiang Li, Guoyin Li, Qiwei Li, Chengjun Li, Jianxiong Li, Ji Li, Huaying Li, Tuojian Li, Yixin Li, Ziyue Li, Juntong Li, Xiang Li, Chaonan Li, Yu-Chia Li, Heying Li, Shaomin Li, Yuxuan Li, Xuan-Ling Li, Bingshan Li, Jiahao Li, Shibao Li, Ruijin Li, Kunlong Li, Xiaofeng Li, Zhaolun Li, Litao Li, Ruyi Li, Wanxin Li, Jinsong Li, Ying-Lan Li, Yulin Li, Shaojian Li, Mohan Li, Yan-Xue Li, Enhong Li, Xiangnan Li, Yong-Jun Li, Hang Li, Ziming Li, Jing-Ming Li, Yuanchang Li, Xiao-Lin Li, Yicun Li, Zhao-Yang Li, K-L Li, Xinjia Li, Bin Li, Jianhai Li, Peiwu Li, Youran Li, Changyu Li, Ming Zhou Li, Z Li, Xinmei Li, Wulan Li, Haoxian Li, Xiaozhao Li, Da-Lei Li, Jinming Li, Huihui Li, Kailong Li, Qiankun Li, Shengxu Li, Xiuli Li, Yulong Li, Ru-Hao Li, Zhi-Peng Li, Lanzhou Li, Tingsong Li, Binjun Li, Chen Li, Yawei Li, Chao Bo Li, Donghua Li, Siming Li, Fengli Li, Song Li, Hsin-Hua Li, You Li, Dongfeng Li, Zhen-Yuan Li, Xuelin Li, Xueyang Li, Bao Li, Yin Li, Cai-Hong Li, Dejun Li, Yufeng Li, Miaoxin Li, Hu Li, Bei Li, W H Li, Sha Li, Ya-Qiang Li, Xiushen Li, Jinlin Li, Xiaoqing Li, Shuaicheng Li, Xuebiao Li, Yingyi Li, Maolin Li, Jiyang Li, Zhongxuan Li, Linting Li, Zhong-Xin Li, Enhao Li, Shengliang Li, Hujie Li, Yue-Ming Li, Zhaohan Li, Alexander Li, Wen-juan Li, Pilong Li, Yun-Peng Li, C X Li, Huanan Li, Miao X Li, KeZhong Li, Linying Li, Chu-Qiao Li, Fa-Hong Li, Changzheng Li, Yaokun Li, Zhi-Gang Li, Yufan Li, Liangqian Li, Guanghui Li, Xiongfeng Li, Side Li, Timmy Li, Jiezhen Li, Qiuya Li, Haitao Li, Yufen Li, Qin Li, Annie Li, Wenge Li, Xueren Li, Chun-Mei Li, Meng-Yao Li, Chung-I Li, Zhi-Bin Li, Junping Li, Xiao Li, PeiQi Li, Xiaobing Li, Liangdong Li, Yan Li, Shengchao A Li, Pan Li, Huiqiong Li, Guigang Li, Lucia M Li, Chunzhu Li, Chengquan Li, Zexu Li, Zhilei Li, Tiantian Li, Wenyong Li, Desen Li, Tianjun Li, Zihao Li, Fadi Li, Huawei Li, Yu-quan Li, Jihua Li, Jingping Li, Zhiquan Li, Zeyu Li, Zongdi Li, Ming V Li, Aowen Li, L K Li, Aimin Li, Tiehua Li, Guohong Li, Botao Li, L-Y Li, Xiuqi Li, Zhenhua Li, Zhengda Li, Haotong Li, Luhan Li, Yuancong Li, Tian Li, Yuxiu Li, Beibei Li, Changhong Li, Yvonne Li, Zhichao Li, Jiayuan Li, Yige Li, Siguang Li, Chengqian Li, Weiye Li, Dong-fei Li, Xiangchun Li, Hailong Li, Kun-Peng Li, Haijun Li, Si Li, Ji-Feng Li, Wanqian Li, Zijing Li, Wentao Li, Yuchuan Li, Xuhong Li, Hongyun Li, Zhonggen Li, Xiong Li, Penghui Li, Huiting Li, Xiaolong Li, Linqing Li, Jiawei Li, Defa Li, X L Li, Yuyan Li, Kawah Li, Shupeng Li, Zhenfei Li, Zhuo Li, Han-Wei Li, Weina Li, Xiao-Hui Li, Rui-Fang Li, Jianzhong Li, Bing Li, Huihuang Li, Yunmin Li, Yanying Li, Gui Lin Li, Dengfeng Li, N Li, Xiaotong Li, Chensheng Li, Ming-Qing Li, Yongxue Li, Bao-Shan Li, Zhimei Li, Jiao Li, Jingming Li, Jinxia Li, De-Tao Li, Shu Li, Julia Li, Huilan Li, Xin-Ya Li, Chunsheng Li, Chengjian Li, Ying-na Li, Guihua Li, Zhiyuan Li, Supeng Li, Yiju Li, Yuanhe Li, Guangxiao Li, Xueqin Li, Peixin Li, Feng-Feng Li, Zu-Ling Li, Yunjiu Li, Dayong Li, Zonghong Li, Lingjiang Li, Yuhan Li, Fuyuan Li, H-F Li, Chunxia Li, Zhen-Li Li, Zhengying Li, Zhaoshui Li, Yali Li, Yu-Hui Li, Chuang Li, Jiajun Li, Can Li, Zhe Li, Stephen Li, Shuangding Li, Mangmang Li, Kaiyuan Li, Xiaopeng Li, Anan Li, Luying Li, Jiajv Li, Xiaoquan Li, Yanxi Li, Yongjing Li, Huayao Li, Jiqing Li, Huixue Li, Boxuan Li, Yongqi Li, Qingyuan Li, Fengqi Li, Yuqing Li, Zhigang Li, Guiyang Li, Guo-Qiang Li, Yanbo Li, Sanqiang Li, Hongyu Li, Guangping Li, Jinxin Li, Xinrong Li, Yayu Li, Huaixing Li, Minyue Li, Hong-Mei Li, Jutang Li, Mengxia Li, Yongxiang Li, Qilong Li, Songlin Li, Dijie Li, Yizhe Li, Yan Bing Li, Jiani Li, Lianjian Li, Yiliang Li, Xinpeng Li, Hongxing Li, Wanyi Li, Mi Li, Guo Li, Jingxia Li, Xiu-Ling Li, Fuhai Li, Ruijia Li, Yumiao Li, Jiexi Li, Kecheng Li, Junxu Li, Junya Li, Jiang Li, Shengxian Li, Qingyang Li, Yuxi Li, Chenxuan Li, Xiao-Dong Li, Xinghuan Li, Zhenlu Li, Xiaolei Li, Huilong Li, Xiao-Gang Li, Zhenhui Li, Chunjun Li, Shu-Fen Li, Yinghua Li, Yanjie Li, Chaoying Li, Juanjuan Li, Qiu Li, Kunlun Li, Shiquan Li, Xiangdong Li, Zhenjia Li, Jifang Li, Zhizhong Li, Ding Yang Li, Chenlong Li, Shujin Li, Weining Li, Wu-Jun Li, Yumao Li, Bin-Kui Li, Honglian Li, Ya-Zhou Li, Hongyi Li, Fu-Rong Li, Honghua Li, Lanjuan Li, Man-Zhi Li, Xiancheng Li, Yanmei Li, Zhihua Li, Minqi Li, Saijuan Li, Danxi Li, Mimi Li, Yingjie Li, Yuan-Hai Li, Lujie Li, Minghao Li, Meifen Li, Yifeng Li, Huanqing Li, Yuhang Li, Jianhua Li, Chanjuan Li, Lingyi Li, Yanchuan Li, Bai-Qiang Li, Chunmiao Li, Jiong-Ming Li, Yongqiang Li, Linsheng Li, Mingyao Li, Ze Li, R H L Li, Guisen Li, Dongyang Li, Jinglin Li, Honglong Li, Mingfang Li, Hanmei Li, Chenmeng Li, Shiyang Li, Jianing Li, Xinsheng Li, Jin-Jiang Li, Zhi-Xing Li, Chang Li, Jiwei Li, Weifeng Li, Wenhui Li, Sichen Li, Qingsheng Li, Liangji Li, Lixiang Li, Jin-Liang Li, Xiaoqiong Li, You Ran Li, Yixiao Li, Kathy H Li, Yuhua Li, Deqiang Li, Y Li, Mingyue Li, Zipeng Li, Caixia Li, Hongli Li, Yanfeng Li, Yaqin Li, Yu-He Li, Shasha Li, S-C Li, Xi Li, Siyi Li, Minmin Li, Manna Li, Dawei Li, Xun Li, Ming-Jiang Li, Sitao Li, Tinghua Li, Zhenfen Li, Shuo Li, Si-Ying Li, Xinyi Li, Jenny J Li, Xue-zhi Li, Xiaonan Li, Zhenyu Li, Ting Li, Xiang-Yu Li, Duan Li, Lei Li, Hongde Li, Fengqing Li, Yanchang Li, Xunjia Li, Ruixia Li, Nanzhen Li, Hongxue Li, Bingjie Li, Xiaojing Li, Xinlin Li, Yu-Ying Li, Wenli Li, Mengze Li, Kaiwei Li, Huangyuan Li, Lili Li, Junxin Li, Wei-Jun Li, Guoyan Li, Fei-Lin Li, Nuomin Li, Yanyan Li, Shulin Li, Shanglai Li, Taibo Li, Yue Li, Junqin Li, JunBo Li, Jun-Ru Li, Xueying Li, Zhongcai Li, Zhaobing Li, Linxin Li, Jen-Ming Li, Chen-Chen Li, Hongquan Li, Chuan F Li, Yanxiang Li, Yi-Wen Li, Shihong Li, Rulin Li, Huifeng Li, Lijuan Li, Yuanhong Li, Shengbin Li, Jingyu Li, Xuewei Li, Long Li, Min-Dian Li, Wenjia Li, Xiatian Li, Yangxue Li, Chengnan Li, Chuanyin Li, Yiqiang Li, Zhenzhou Li, Xiawei Li, Binglan Li, Yutong Li, Yingnan Li, Ge Li, Xinzhong Li, Chenyao Li, Jun-Yan Li, Boru Li, Ruixue Li, Zemin Li, Jixi Li, Chris Li, Jicheng Li, Chuanning Li, Jiafei Li, Yingying Li, Gaizhi Li, Chien-Hsiu Li, Xiangcheng Li, Siqi Li, Chunxing Li, Qiao-Xin Li, Huang Li, Shu-Fang Li, Qiusheng Li, Weiqin Li, Xinming Li, Yongjun Li, Mengyang Li, Guo-Jian Li, Chenglong Li, Nan Li, Yipeng Li, Mingxing Li, Xin-Yu Li, Chunyu Li, Jinwei Li, Xuhua Li, Yu-Xiang Li, Long Shan Li, Yanze Li, Xiao-Feng Li, W Li, Fengjuan Li, Hainan Li, Yutian Li, Xiliang Li, Shuangmei Li, Ying-Bo Li, Duanbin Li, Maogui Li, Dan Li, Sumei Li, Peilong Li, Kang Li, Yinghao Li, Lirong Li, Wenhong Li, Audrey Li, Yijian Li, Guang Y Li, Xianyong Li, Shilan Li, Guang-Li Li, Bang-Yan Li, Enxiao Li, Jianrui Li, Guohua Li, Kezhen Li, Xingxing Li, Ellen Li, Yijie Li, Suwei Li, Shuyu D Li, Ruiwen Li, Jiandong Li, Fangyong Li, Binru Li, Yuchao Li, Hanlu Li, Jianang Li, Xue-Peng Li, Sheng-Tien Li, Shihao Li, Yazhou Li, Jun-Ling Li, Caesar Z Li, Lang Li, Feifei Li, Kejuan Li, Qinghong Li, Qiqiong Li, Xinxiu Li, Chongyi Li, Yi-Ying Li, Shaodan Li, Yongzheng Li, Da-Hong Li, Xiao-mei Li, Jiejie Li, Ruihuan Li, Yaoyao Li, Yueguo Li, Mo Li, Ming-Hao Li, Hongsen Li, Menghua Li, Ka Li, Kaixin Li, Fuping Li, Jianbo Li, Xing-Wang Li, Chong Li, Fugen Li, Yuwei Li, Xiaochen Li, Zizhuo Li, Xiaoxiao Li, Le-Ying Li, Pengcui Li, Bing-Heng Li, Xiaoman Li, Xiaohong Li, Yuan Hao Li, Jianchun Li, Wenxiang Li, Zhaoliang Li, Guo-Ping Li, Zhifei Li, Jinhui Li, Yuanyou Li, Chongyang Li, Wanyan Li, Yumin Li, Longyu Li, X B Li, Jianguo Li, En Li, Ximei Li, Shaoyong Li, Kai-Wen Li, Guandu Li, Yixue Li, Junfeng Li, Xin-Chang Li, Yue-Ying Li, Kongdong Li, Lian Li, Xinmiao Li, Chenyang Li, Jiacheng Li, Xiaohua Li, Zhuangzhuang Li, Xiaohui Li, Cang Li, Xuepeng Li, Mingjiang Li, Zongyu Li, Shujie Li, Yanbin Li, Shiliang Li, Qinrui Li, Yiming Li, Xiao-Tong Li, Tie Li, Wei-Bo Li, Xiaoyi Li, Liyan Li, Xinke Li, Xiaokun Li, Ming-Wei Li, Minzhe Li, Wenfeng Li, Karen Li, X Li, Meifang Li, Yanjing Li, Maosheng Li, Ju-Rong Li, Shibo Li, Jin Li, Li-Na Li, Hui Li, Fangqi Li, Xiaoguang Li, Xian Li, Danjie Li, Vivian S W Li, Ranchang Li, Defu Li, Amy Li, Haoyu Li, Xiaoyao Li, M-J Li, Jiao-Jiao Li, Zhu Li, Rongling Li, Tong-Ruei Li, Ben Li, Yingxia Li, Yonghe Li, Xinwei Li, Yu-I Li, Shunhua Li, Mingxi Li, Qionghua Li, Guo-Li Li, Xingchen Li, Tianjiao Li, Gui-Rong Li, Yunpeng Li, Qiong Li, Songyu Li, Shi-Fang Li, Shude Li, Zhibin Li, Yaxiong Li, Qing-Fang Li, Shengwen Li, Gui-Bo Li, Xueer Li, Zihai Li, Yue-Jia Li, Haihong Li, Peifen Li, Mingzhou Li, Taixu Li, Jiejing Li, Meng-Miao Li, Meiying Li, Chunlian Li, Meng Li, Cun Li, T Li, Yinghui Li, Feilong Li, Sin-Lun Li, Weiling Li, Mengfan Li, Jie Li, Shiyan Li, Lianbing Li, Yanchun Li, Xuze Li, Jialin Li, Wenjian Li, He Li, Bichun Li, Hanqin Li, Guoge Li, Wen-Wen Li, Keying Li, Minze Li, Xingcheng Li, Wanshun Li, Congxin Li, Xiangrui Li, Caolong Li, Michelle Li, Chaojie Li, J Li, Zhi-Jian Li, Jianwei Li, Jiexin Li, Hongyan Li, Zhen-Xi Li, Guangdi Li, Xiaxia Li, Nien Li, Yuefeng Li, Peiyuan Li, Tiansen Li, Chi-Yuan Li, Xiangfei Li, Xue Li, Fen Li, Jieshou Li, Roger Li, Mengqing Li, Menglu Li, Huiqing Li, Yantao Li, Ruolin Li, Yongle Li, Haying Li, Shao-Dan Li, Muzi Li, Gen Li, Dong-Ling Li, Chenwen Li, Le Li, Yong-Jian Li, Si-Wei Li, Manru Li, Yingxi Li, Caili Li, Yuqian Li, Wei-Dong Li, Guannan Li, Ya-Feng Li, Wenlong Li, Yuna Li, Shengli Li, Shugang Li, Xuan Li, Yongze Li, Yongxin Li, Lu Li, Zhuo-Rong Li, Qinglin Li, Bingbing Li, Runzhi Li, Qi-Jing Li, Zhenyan Li, Ji Xia Li, Yu-Ye Li, Meizi Li, Yuezheng Li, Zhengnan Li, Jianglong Li, Xiaozheng Li, Huili Li, Hongzhe K Li, Xiao-Qiu Li, Jiejia Li, Yi-Yang Li, Zhihui Li, Fujun Li, Ni Li, Luxuan Li, Qiang-Ming Li, Yakui Li, Huafu Li, Xinye Li, Chunliang Li, Ruiyang Li, Chun Li, Jianan Li, Wenfang Li, Xiangling Li, Sung-Chou Li, Lianhong Li, Cheng Li, Tiegang Li, Zhong Li, Shuang-Ling Li, Xiao-Long Li, Xiaofei Li, Hung-Yuan Li, Zhang Li, Jianxin Li, H Li, Dongliang Li, Chenxiao Li, Hongjia Li, Xiao-Jing Li, Y H Li, Jian Li, Daoyuan Li, Baichuan Li, Zhenzhe Li, Jian-Mei Li, Kaimi Li, Peiran Li, Qiao Li, Yi-Yun Li, Xiao-Cheng Li, Yike Li, Yihan Li, Junsheng Li, Jiayu Li, Wen-Ya Li, Rongxia Li, Yunlun Li, Guoqin Li, Huiqin Li, Chunlin Li, Jisen Li, Peng Peng Li, Kenli Li, Guanglu Li, Xiushi Li, Dongmin Li, Jian-Jun Li, Fengyi Li, Yanling Li, Juanni Li, C Li, You-Mei Li, Beixu Li, Guiyuan Li, Suk-Yee Li, Shengjie Li, Yuanyuan Li, Xiaona Li, Shanyi Li, Chih-Chi Li, Hongbo Li, Xinhui Li, Jun Li, Mingzhe Li, Hongjuan Li, Senmao Li, Mingjie Li, Ling-Jie Li, Hong-Chun Li, Yaying Li, Liqun Li, Changxian Li, Chunqing Li, Yanni Li, Yongsheng Li, Xiujuan Li, Huifang Li, Lingling Li, Xinhua Li, Minerva X Li, Alexander H Li, Wendeng Li, Ding Li, Ming-Yang Li, Shengze Li, Linyan Li, Hewei Li, Da-Jin Li, Xiao-kun Li, Yuanhao Li, Ji-Lin Li, Congcong Li, Juan Li, Xiaobin Li, Shaoqi Li, Yuehua Li, Jinfeng Li, Shiheng Li, Hsiao-Fen Li, Mengjiao Li, Tianxiang Li, Meng-Meng Li, Liangkui Li, Tian-chang Li, Yahui Li, Wenlei Li, Xi-Xi Li, Haiyan Li, Xujun Li, Chi-Ming Li, Yi-Ning Li, Dandan Li, Yunan Li, Sherly X Li, Jiazhou Li, Zhijun Li, Zechuan Li, Wanling Li, Zhiwei Li, Xueshan Li, Jiangbo Li, Xiaohan Li, Huijie Li, Zhongwen Li, W W Li, Yalan Li, Xuejun Li, Shunwang Li, Yaqing Li, Chao Li, Yaqiao Li, Bingsheng Li, Jianfang Li, Shubo Li, Qi-Fu Li, Zi-Zhan Li, Haoran Li, Xiaoliang Li, Xinyuan Li, Maoquan Li, Chumei Li, Shijie Li, Zhanquan Li, Wenguo Li, Fangyuan Li, Xiaochun Li, Rui Li, Xuemin Li, Shanpeng Li, Wei-Na Li, Dong-Run Li, Yunxi Li, Xuyi Li, Yunchu Li, Zhengyao Li, Jinghao Li, Y-Y Li, Xiaofang Li, Tuoping Li, Pengyun Li, Lin-Feng Li, Ziqing Li, Shuangxiu Li, Yongjin Li, Chenhao Li, Weizu Li, Deming Li, Jiuyi Li, Chun-Xu Li, Luyao Li, Desheng Li, Long-Yan Li, Fuyu Li, Lingzhi Li, Xiao-Sa Li, Kunlin Li, Shu-Qi Li, Zehua Li, Mengyuan Li, Congye Li, Wensheng Li, Dehai Li, Qingshang Li, Jiannan Li, Guanbin Li, Zhiyi Li, Xing Li, Zhaoyong Li, SuYun Li, Shiyi Li, Suchun Li, Yanan Li, Jiayan Li, YueQiang Li, Xiangping Li, H-H Li, Jinman Li, Dongdong Li, Hao Li, Liliang Li, Mengxi Li, Keyuan Li, Shaojing Li, S S Li, Tong Li, Yilong Li, Lihua Li, Xue-Lian Li, Yansen Li, Hai Li, Zhi-Yuan Li, Jingfeng Li, Yanli Li, Yuan-Jing Li, Kaibin Li, Xiaohu Li, Wenjie Li, Ruikai Li, Qiyong Li, Ruixi Li, Zhonglian Li, Dalin Li, Kun Li, Qizhai Li, Pengju Li, Peifeng Li, Ai-Jun Li, Yueting Li, YaJie Li, Zijian Li, Yanqing Li, Jixuan Li, Zhandong Li, Xuejie Li, Gaizhen Li, Liang Li, Huafang Li, Nianyu Li, Chenlu Li, X-L Li, Shawn S C Li, Cuiguang Li, Dongye Li, F Li, Chunhong Li, Yuan Li, Kunpeng Li, Zhenghao Li, Chun-Bo Li, Zhantao Li, Xinle Li, Wuguo Li, Bing-Hui Li, Honggang Li, Jingyong Li, Shikang Li, Shi-Ying Li, Ming Xing Li, Ming-Xing Li, Marilyn Li, Bei-Bei Li, Hong-Lian Li, Shishi Li, Haitong Li, Yuli Li, Ruibing Li, Qingfang Li, Qibing Li, Wende Li, Heng Li, Xiao-Na Li, Xidan Li, Yixing Li, Chengcheng Li, Yu-Jin Li, Baoting Li, Ka Wan Li, Huiyou Li, Binbin Li, Xinyao Li, Gui-xing Li, Niu Li, Shunle Li, Siyue Li, Diyan Li, Mengyao Li, Yixuan Li, Shan-Shan Li, Zhuanjian Li, Gerard Li, Yuyun Li, Zhiqiong Li, Zonglin Li, Pik Yi Li, Jingxin Li, Defeng Li, Zu-guo Li, Xin-Zhu Li, Jia-Xin Li, Kuiliang Li, Pindong Li, Hualian Li, Junhong Li, Youchen Li, W Y Li, Yi-Heng Li, Runbing Li, Yanmin Li, Jingyi Li, Yuxiang Li, Hao-Fei Li, Yining Li, Xiurong Li, Haiyu Li, Huijuan Li, Yunze Li, Xu-Zhao Li, Yanzhong Li, Kainan Li, Guohui Li, Xiaoyan Li, Xu-Bo Li, Yue-Chun Li, Jiahui Li, Huiping Li, Kangyuan Li, Biao Li, Xiaoxuan Li, Anyao Li, Qing-Chang Li, Hongliang Li, Dalei Li, Zongjun Li, Changqing Li, Hanting Li, Dong-Jie Li, Xiaomin Li, Dengxiong Li, Yi-Shuan J Li, Tinghao Li, Zhouxiang Li, Yun-tian Li, Jianliang Li, Guangzhao Li, Yixi Li, Shuyu Dan Li, S A Li, Jinjie Li, Liming Li, Wenqun Li, Guixia Li, Yinan Li, Aoxi Li, Yuanjing Li, Linqi Li, Xixi Li, Bingjue Li, Binghu Li, Yu-Hang Li, Shuhui Li, Mengying Li, Yihong Li, Yaxian Li, Dali Li, Zhiming Li, Xuemei Li, Xueting Li, Yongting Li, Hongxia Li, Zhenjun Li, Danyang Li, Tiandong Li, Di-Jie Li, Bo Li, Jinliang Li, Qiji Li, Zhipeng Li, Xiaoping Li, Linhong Li, Taoyingnan Li, Lieyou Li, Huabin Li, Mao Li, Yongchao Li, Xiaoting Li, Ruotai Li, Yaojia Li, Xiao-Yao Li, Shangming Li, Yaqi Li, Yibo Li, Gui-Hua Li, Zhihong Li, Yandong Li, Chaowei Li, Huiyuan Li, Yuchun Li, Boya Li, Lamei Li, O Li, Joyce Li, Suheng Li, Hui-Ping Li, Junru Li, Zhiqiang Li, Jiangchao Li, Hecheng Li, Yueping Li, Changkai Li, Zhenglong Li, Yajuan Li, Chaoqian Li, Yu-Cheng Li, Yirun Li, Haomiao Li, Qianqian Li, YiQing Li, Zhengliang Li, Weijie Li, Wei-Qin Li, Zongyi Li, Qingxian Li, Dan-Dan Li, Yeshan Li, Zirui Li, Keke Li, Yongpeng Li, Chanyuan Li, Jianbin Li, Shiying Li, Zhongzhe Li, Yumei Li, Xiang-Ping Li, Wenqiang Li, Pei-Shan Li, Zaibo Li, Guangming Li, Xiaoqiang Li, Hanxiao Li, Jiansheng Li, Shuying Li, Xiaomei Li, Pengjie Li, Jiajia Li, Jingwen Li
articles
Xinruo Zhang, Jennifer A Brody, Mariaelisa Graff +122 more · 2025 · Nature communications · Nature · added 2026-04-24
Xinruo Zhang, Jennifer A Brody, Mariaelisa Graff, Heather M Highland, Nathalie Chami, Hanfei Xu, Zhe Wang, Kendra R Ferrier, Geetha Chittoor, Navya Shilpa Josyula, Mariah Meyer, Shreyash Gupta, Xihao Li, Zilin Li, Matthew A Allison, Diane M Becker, Lawrence F Bielak, Joshua C Bis, Meher Preethi Boorgula, Donald W Bowden, Jai G Broome, Erin J Buth, Christopher S Carlson, Kyong-Mi Chang, Sameer Chavan, Yen-Feng Chiu, Lee-Ming Chuang, Matthew P Conomos, Dawn L DeMeo, Mengmeng Du, Ravindranath Duggirala, Celeste Eng, Alison E Fohner, Barry I Freedman, Melanie E Garrett, Xiuqing Guo, Chris Haiman, Benjamin D Heavner, Bertha Hidalgo, James E Hixson, Yuk-Lam Ho, Brian D Hobbs, Donglei Hu, Qin Hui, Chii-Min Hwu, Rebecca D Jackson, Deepti Jain, Rita R Kalyani, Sharon L R Kardia, Tanika N Kelly, Ethan M Lange, Michael LeNoir, Changwei Li, Loic Le Marchand, Merry-Lynn N McDonald, Caitlin P McHugh, Alanna C Morrison, Take Naseri, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Jeffrey O'Connell, Christopher J O'Donnell, Nicholette D Palmer, James S Pankow, James A Perry, Ulrike Peters, Michael H Preuss, D C Rao, Elizabeth A Regan, Sefuiva M Reupena, Dan M Roden, Jose Rodriguez-Santana, Colleen M Sitlani, Jennifer A Smith, Hemant K Tiwari, Ramachandran S Vasan, Zeyuan Wang, Daniel E Weeks, Jennifer Wessel, Kerri L Wiggins, Lynne R Wilkens, Peter W F Wilson, Lisa R Yanek, Zachary T Yoneda, Wei Zhao, Sebastian Zöllner, Donna K Arnett, Allison E Ashley-Koch, Kathleen C Barnes, John Blangero, Eric Boerwinkle, Esteban G Burchard, April P Carson, Daniel I Chasman, Yii-der Ida Chen, Joanne E Curran, Myriam Fornage, Victor R Gordeuk, Jiang He, Susan R Heckbert, Lifang Hou, Marguerite R Irvin, Charles Kooperberg, Ryan L Minster, Braxton D Mitchell, Mehdi Nouraie, Bruce M Psaty, Laura M Raffield, Alexander P Reiner, Stephen S Rich, Jerome I Rotter, M Benjamin Shoemaker, Nicholas L Smith, Kent D Taylor, Marilyn J Telen, Scott T Weiss, Yingze Zhang, Nancy Heard-Costa, Yan V Sun, Xihong Lin, L Adrienne Cupples, Leslie A Lange, Ching-Ti Liu, Ruth J F Loos, Kari E North, Anne E Justice Show less
Obesity is a major public health crisis associated with high mortality rates. Previous genome-wide association studies (GWAS) investigating body mass index (BMI) have largely relied on imputed data fr Show more
Obesity is a major public health crisis associated with high mortality rates. Previous genome-wide association studies (GWAS) investigating body mass index (BMI) have largely relied on imputed data from European individuals. This study leveraged whole-genome sequencing (WGS) data from 88,873 participants from the Trans-Omics for Precision Medicine (TOPMed) Program, of which 51% were of non-European population groups. We discovered 18 BMI-associated signals (P < 5 × 10 Show less
no PDF DOI: 10.1038/s41467-025-58420-2
POC5
Shuo Wang, Yunhui Lv, Xiaohu Wang +17 more · 2025 · Journal of nanobiotechnology · BioMed Central · added 2026-04-24
Impaired excretion of lipid deposits within vascular smooth muscle cell-derived foam cells (VSMC-FCs) contributes to the ongoing expansion of the plaque necrotic core. This study aims to explore the e Show more
Impaired excretion of lipid deposits within vascular smooth muscle cell-derived foam cells (VSMC-FCs) contributes to the ongoing expansion of the plaque necrotic core. This study aims to explore the effects and underlying mechanisms of exosomes secreted by M2 macrophage (M2-exos) on lipid metabolism of VSMC-FCs and plaque stability. First, immunofluorescence was used to detect the expression levels of CD45 (a recognized differentially-expressed molecule of myeloid and VSMC-FCs) and the key proteins of cholesterol efflux pathway, ABCA1 and ABCG1, in human early and late plaques. Next, an in vitro foam cell model was used to assess the effect and mechanism of M2-exos on lipid metabolism in vascular smooth muscle cells by western blot, Oil red O staining and cell total cholesterol assays. RNA-seq and quantitative real-time PCR were employed to characterize the miRNA profiles within M2-exos. The dual-luciferase reporting system and gene silencing approaches were utilized to assess the regulatory effect of candidate miRNA on target genes and signaling pathways. Subsequently, the effect of M2-exos on plaque progression and stability in ApoE Immunofluorescence revealed that compared to early plaques, VSMC-FCs (CD45 M2-exos exerted an obvious atherosclerotic protective effect, and the underlying mechanism was closely related to MiR-7683-3p, which targeted the 3'UTR of HOXA1 mRNA and activated the PPARγ-LXRα-ABCG1 mediated cholesterol efflux in VSMC-FCs. Show less
no PDF DOI: 10.1186/s12951-025-03690-7
NR1H3
Xuejiao Lei, Xiaodong Ran, Jiawei Wang +7 more · 2025 · Life sciences · Elsevier · added 2026-04-24
CKN is a self-developed LXRα agonist capable of up-regulating the expression of ABCA1, diminishing intracellular lipid deposition, and attenuating the inflammatory response. Nevertheless, the protecti Show more
CKN is a self-developed LXRα agonist capable of up-regulating the expression of ABCA1, diminishing intracellular lipid deposition, and attenuating the inflammatory response. Nevertheless, the protective effect and mechanism of ischemic stroke remain indistinct. The aim of this study is to investigate the therapeutic effects and the underlying mechanisms of CKN in ischemic stroke. In this study, the tMCAO model was utilized to induce cerebral artery occlusion in mice, and cholesterol-induced BV2 and primary microglia models were adopted. Neuronal damage and the effect of CKN on ABCA1 expression, lipid deposition, and TLR4 signaling in penumbra microglia were assessed. The results demonstrated that: (1) CKN treatment markedly ameliorated the neurological deficit score of the tMCAO model, contracted the infarct size, and mitigated the damage of the cerebral cortex. (2) CKN has the capacity to up-regulate the expression of ABCA1 in microglia within the ischemic penumbra by activating the LXRα/ABCA1 signaling pathway, and minimize lipid deposition and inflammatory responses. (3) The activation of the LXRα/ABCA1 signaling pathway is profoundly implicated in the inflammatory response triggered by CKN inhibition of the TLR4 signaling pathway in microglia. The present study demonstrated for the first time that the activation of the LXRα/ABCA1 signaling possessed the ability to attenuate reperfusion injury in ischemic stroke by means of reducing lipid droplet formation and TLR4-mediated inflammatory signaling within microglia in the ischemic penumbra. Show less
no PDF DOI: 10.1016/j.lfs.2025.123571
NR1H3
Yi-Jia Liu, Jian Guo, Chang-Da Li +2 more · 2025 · Frontiers in physiology · Frontiers · added 2026-04-24
Intensive aquaculture frequently utilizes high-fat diets (HF) as a cost-effective strategy, yet this practice often induces hepatic steatosis, oxidative stress, and chronic inflammation in carnivorous Show more
Intensive aquaculture frequently utilizes high-fat diets (HF) as a cost-effective strategy, yet this practice often induces hepatic steatosis, oxidative stress, and chronic inflammation in carnivorous fish. Betaine, a natural methyl donor, has shown potential as a functional feed additive, but its comprehensive protective mechanisms under HF stress remain to be fully elucidated. Juvenile largemouth bass (Micropterus salmoides) were fed one of four isonitrogenous diets for 8 weeks: a normal-fat control (Control), a high-fat diet (HF), and two high-fat diets supplemented with 0.5% (HFB0.5) or 1.0% (HFB1) betaine. Growth performance, digestive enzyme activities, serum biochemical parameters, hepatic antioxidant capacity, and the expression of genes related to antioxidant defense, lipid metabolism, and inflammation were analyzed. The HF group exhibited significantly impaired growth, digestive function, and antioxidant capacity, along with elevated lipid peroxidation, dyslipidemia, and pro-inflammatory cytokine expression. Betaine supplementation restored growth performance and feed efficiency to control levels, ameliorated digestive enzyme activities (particularly enhancing lipase), and activated the hepatic Nrf2-Keap1 pathway, upregulating antioxidant genes (nrf2, sod1, cat, gpx, ho-1, gr) and enhancing enzyme activities. Betaine also improved serum lipid profiles, upregulated genes related to fatty acid oxidation (pparα, cpt-1) and lipolysis (lpl, hsl), suppressed lipogenic genes (srebp-1, fas), and rebalanced inflammatory cytokines by reducing tnf-α and il-1β while increasing tgf-β1 and il-10. Dietary betaine effectively counteracts HF-induced metabolic stress in M. salmoides through coordinated multi-pathway regulation. It enhances antioxidant defense, reprograms hepatic lipid metabolism toward catabolism, and restores inflammatory homeostasis. These findings underscore betaine's role as a multi-functional feed additive capable of mitigating HF-related metabolic disorders and promoting overall health in carnivorous fish aquaculture. Show less
📄 PDF DOI: 10.3389/fphys.2025.1742669
LPL
Huijie Yang, Fangyu Wang, Peijun Zhao +12 more · 2025 · International journal of biological macromolecules · Elsevier · added 2026-04-24
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by hyperphosphorylation of tau, neuroinflammation, and amyloid-beta (Aβ) plaques. Lead (Pb) exposure has been linked to an increa Show more
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by hyperphosphorylation of tau, neuroinflammation, and amyloid-beta (Aβ) plaques. Lead (Pb) exposure has been linked to an increased risk of AD and neuroinflammation. The purpose of this study is to determine if black soybean peptide (BSP1) may reduce neuroinflammation caused by Pb and associated AD-like pathology. Pb exposure was given to mouse hippocampus HT22 cells in the presence or absence of BSP1, positive control resveratrol (Rsv), or the SIRT1 inhibitor EX-527. Our findings suggest that BSP1 downregulates the expression of beta-secretase (BACE1) and amyloid precursor protein (APP), inhibits tau phosphorylation, and reduces Aβ1-42 deposition. In addition, BSP1 effectively alleviated Pb-induced neuroinflammation by reducing the phosphorylation of NF-κB and the expression of pro-inflammatory cytokines (IL-1β, TNF-α, NLRP3, and IL-18). BSP1 provides neuroprotective effect via phosphorylating LKB1 and AMPK, inhibiting mTOR signaling, and activating the AMPK/SIRT1 pathway. These results suggest that BSP1 may be therapeutically beneficial for preventing or treating AD by reducing Pb-induced neuroinflammation. Show less
no PDF DOI: 10.1016/j.ijbiomac.2024.138404
BACE1
Zehan Li, Huazhen Wu, Chuzhong Wei +15 more · 2025 · 3 Biotech · Springer · added 2026-04-24
By integrating single-cell and bulk RNA-sequencing data for esophageal cancer (ESCA), we developed and validated a seven-macrophage-gene prognostic signature (FCN1, SCARB2, ATF5, PHLDA2, GLIPR1, CHORD Show more
By integrating single-cell and bulk RNA-sequencing data for esophageal cancer (ESCA), we developed and validated a seven-macrophage-gene prognostic signature (FCN1, SCARB2, ATF5, PHLDA2, GLIPR1, CHORDC1, and BCKDK). This signature effectively stratified patients into high- and low-risk groups with significantly different overall survival, achieving area under the curve (AUC) values greater than 0.7 for 1-, 2-, and 3-year survival prediction. A high-risk status correlated with an immunosuppressive tumor microenvironment, characterized by lower infiltration of B cells and CD8 + T cells, and was associated with reduced sensitivity to multiple chemotherapeutic agents, including Cisplatin and 5-Fluorouracil. Conversely, a low-risk status was linked to greater immune cell infiltration and higher predicted chemosensitivity. At the single-cell level, pseudotime analysis revealed that macrophage maturation significantly correlated with a decreasing risk score, suggesting that mature macrophages may contribute to a favorable prognosis. Furthermore, cell communication analysis identified high-risk macrophages as dominant drivers of a pro-tumorigenic microenvironment via signaling pathways, such as SPP1 and complement. In conclusion, this seven-gene signature is a robust prognostic biomarker that offers a new strategy for personalized risk assessment and treatment selection in ESCA. The online version contains supplementary material available at 10.1007/s13205-025-04452-w. Show less
no PDF DOI: 10.1007/s13205-025-04452-w
BCKDK
Xuan Bai, Dingzi Zhou, Jing Luo +14 more · 2025 · Medicine · added 2026-04-24
Lipid metabolism abnormalities and inflammation have been implicated in gallstone disease (GSD) development, but the causal relationships and potential mediation effects among lipid metabolites, infla Show more
Lipid metabolism abnormalities and inflammation have been implicated in gallstone disease (GSD) development, but the causal relationships and potential mediation effects among lipid metabolites, inflammatory factors, and GSD remain unclear. The aim of this study is to explore the causal relationships among these 3 factors. This study employed 2-sample Mendelian Randomization (TSMR) and 2-step MR to investigate the causal relationships and potential mediation effects among 91 inflammatory factors, 6 lipid metabolism-related molecules (HDL-C, LDL-C, TG, total cholesterol, ApoA1, and ApoB), and GSD. We opted for 4 distinct MR analysis methods including inverse variance weighted method, weighted median method, MR-Egger regression method and MR-PRESSO analysis. Sensitivity analyses included MR-Egger intercept tests, Cochran's Q statistic, Steiger tests, and leave-one-out analyses. Product of coefficients method was used to estimate mediation proportion. TSMR analysis revealed that every 1-unit increase in low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein A1 (ApoA1), and apolipoprotein B (ApoB), the risk of GSD decreased by 16.5%, 10.2%, 8.4%, and 13.1%, respectively. Inflammatory factors such as Natural killer cell receptor 2B4 (CD244), Macrophage colony-stimulating factor 1 (CSF-1), and interleukin-18 receptor 1 (IL-18R1) were identified as risk factors for GSD, while Fibroblast growth factor 19 levels (FGF19), Interleukin-1-alpha levels (IL-1α), and Interleukin-8 levels (IL-8) were found to be protective. Mediation analysis through 2-step MR identified potential pathways involving ApoA1--IL-8--GSD (P = .084) and IL-1α--ApoB--GSD (P = .117). This study provides robust evidence of causal links between specific lipid metabolites and GSD, as well as suggestive causal associations for several inflammatory factors. However, mediation analysis did not support significant roles for lipids or inflammatory factors as mediators in GSD pathogenesis. Future research could be further pursued in areas such as drug target intervention and mechanistic studies. Show less
no PDF DOI: 10.1097/MD.0000000000044704
APOB
Xiaotao Jiang, Hui Wu, Ning Yan +14 more · 2025 · Research (Washington, D.C.) · added 2026-04-24
The development of an immunosuppressive microenvironment is a critical factor in stomach carcinogenesis. Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) serve a pivotal function in medi Show more
The development of an immunosuppressive microenvironment is a critical factor in stomach carcinogenesis. Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) serve a pivotal function in mediating immune suppression. However, the precise mechanisms underlying PMN-MDSCs infiltration into the tumor immune microenvironment (TIME) and their immunosuppressive functions remain poorly understood. In this investigation, we observed that PMN-MDSCs were up-regulated during stomach carcinogenesis, with gastric cancer (GC) cells secreting CCL26 to promote the infiltration of PMN-MDSCs into the TIME via the CX3CR1 receptor. The infiltrating CX3CR1 Show less
no PDF DOI: 10.34133/research.1002
SNAI1
Ziqiang Lin, Jiade Chen, Yutai Cai +16 more · 2025 · BMC public health · BioMed Central · added 2026-04-24
The mediation effect of 24-hour physical activities on the association between type 2 diabetes and mortality is unclear. Additionally, Little evidence was found on the isotemporal substitution effect Show more
The mediation effect of 24-hour physical activities on the association between type 2 diabetes and mortality is unclear. Additionally, Little evidence was found on the isotemporal substitution effect of 24-hour physical activities components on changing Life expectancy among patients with type 2 diabetes diagnosed. To address the abovementioned research gap, the study has a two-fold aims: first, to examine the mediation effect of 24-hour physical activities in type 2 diabetes and mortality; and second, to address how reallocating time on different daily activities would affect life expectancy. Analysis was conducted on the accelerometer data of 103,359 participants in the UK Biobank, with a median age of 57 years (range 39 to 70). Compositional mediation cox model was conducted to analyze the mediating effects of 24-hour physical activities. Additionally, the cohort Life table method was utilized to estimate the changes of Life-years over the next 10 years resulting from the substitution effect of different physical activities. During a mean follow-up of 13.95 (range 2.95-16.28) years, 2,649 deaths were recorded. Diabetes was significantly associated with increased time spent engaging in sedentary behavior (SB), and reduced time spent on moderate-to-vigorous physical activity (MVPA) and light-intensive physical activity (LPA), thereby demonstrating an association with higher mortality risk. The indirect effect of physical activity (HR = 1.27, 95% CI 1.23-1.30) accounted for 41.9% of the total effect of diabetes on mortality. Furthermore, the Life expectancy gains with a maximum of 1.32 years over the next 10 years was found when reallocating SB time to MVPA. The results revealed that 24-hour physical activities might mediate the association between diabetes and mortality. Therefore, promoting participation in MVPA and reducing sedentary activities among diabetes patients was expected to have a positive effect on Life expectancy over the next 10 years. Show less
📄 PDF DOI: 10.1186/s12889-025-24662-4
LPA
Pengfei Zhang, Wenting Wang, Qian Xu +5 more · 2025 · Atherosclerosis · Elsevier · added 2026-04-24
Vascular calcification (VC) significantly increases the incidence and mortality of many diseases. The causal relationships of dyslipidaemia and lipid-lowering drug use with VC severity remain unclear. Show more
Vascular calcification (VC) significantly increases the incidence and mortality of many diseases. The causal relationships of dyslipidaemia and lipid-lowering drug use with VC severity remain unclear. This study explores the genetic causal associations of different circulating lipids and lipid-lowering drug targets with coronary artery calcification (CAC) and abdominal aortic artery calcification (AAC). We obtained single-nucleotide polymorphisms (SNPs) and expression quantitative trait loci (eQTLs) associated with seven circulating lipids and 13 lipid-lowering drug targets from publicly available genome-wide association studies and eQTL databases. Causal associations were investigated by univariable, multivariable, drug-target, and summary data-based Mendelian randomization (MR) analyses. Potential mediation effects of metabolic risk factors were evaluated. MR analysis revealed that genetic proxies for low-density lipoprotein cholesterol (LDL-C), triglycerides (TC) and Lipoprotein (a) (Lp(a)) were causally associated with CAC severity, and apolipoprotein B (apoB) level was causally associated with AAC severity. A significant association was detected between hepatic Lipoprotein(A) (LPA) gene expression and CAC severity. Colocalisation analysis supported the hypothesis that the association between LPA expression and CAC quantity is driven by different causal variant sites within the ±1 Mb flanking region of LPA. Serum calcium and phosphorus had causal associations with CAC severity. Inhibitors targeting LPA might represent CAC drug candidates. Moreover, T2DM, hypercalcemia, and hyperphosphatemia are positively causally associated with CAC severity, while chronic kidney disease and estimated glomerular filtration rate are not. Show less
no PDF DOI: 10.1016/j.atherosclerosis.2025.119136
APOB
Menghan Lv, Xuan Wang, Xiayue He +4 more · 2025 · Frontiers in psychiatry · Frontiers · added 2026-04-24
Obesity and dysregulated cytokine levels are prevalent in schizophrenia patients undergoing antipsychotic treatment. While cytokines are implicated in obesity, their relationship with psychopathology Show more
Obesity and dysregulated cytokine levels are prevalent in schizophrenia patients undergoing antipsychotic treatment. While cytokines are implicated in obesity, their relationship with psychopathology in schizophrenia remains underexplored. This study investigated associations between body mass index (BMI), cytokine levels, and clinical symptoms in chronic schizophrenia patients. In this cross-sectional study,201chronic schizophrenia patients (Chinese Han population) were stratified into high BMI (BMI≥25kg/m A significant negative correlation was observed between BMI and IL-2( Higher BMI in chronic schizophrenia is associated with reduced IL-2 levels, attenuated negative symptoms, and adverse lipid profiles. TNF-α may modulate psychopathology severity. These findings highlight complex interactions between metabolic dysregulation, immune markers, and clinical manifestations in schizophrenia. Show less
📄 PDF DOI: 10.3389/fpsyt.2025.1574041
APOB
Xuliang Luo, Yan Guo, Xuelian Li +6 more · 2025 · BMC genomics · BioMed Central · added 2026-04-24
Aromatase, encoded by Cyp19a1, is the rate limiting enzyme in biosynthesis of estrogens, and excessive aromatase can reduce the semen quality in roosters. Seminal plasma extracellular vesicles (SPEV) Show more
Aromatase, encoded by Cyp19a1, is the rate limiting enzyme in biosynthesis of estrogens, and excessive aromatase can reduce the semen quality in roosters. Seminal plasma extracellular vesicles (SPEV) are nanoscale vesicles that carry and transmit signaling molecules, thereby affecting semen quality. Currently it is still unclear whether SPEV are involved in the process of that aromatase affects the quality semen in chicken. To clarify this issue, lentivirus carrying Cyp19a1 (LV-CYP19A1) for over-expression of aromatase was constructed and injected to testis of 35-week-old roosters. Semen quality and seminal plasma hormone were measured, and SPEV were also extracted and proteome sequencing was performed after treatment of LV-CYP19A1. The results indicated that semen volume, fertility, sperm motility, testosterone (T) levels were significantly decreased, and estradiol (E Our results reveal that aromatase can down-regulate the protein expression related to regulation of ATP synthesis and metabolism, and sperm motility in SPEV, thereby reducing semen quality in roosters. Show less
📄 PDF DOI: 10.1186/s12864-025-11500-5
APOB
Jessica Blumenfeld, Yaqiao Li, Min Joo Kim +12 more · 2025 · bioRxiv : the preprint server for biology · Cold Spring Harbor Laboratory · added 2026-04-24
Apolipoprotein E4 (APOE4), the strongest genetic risk factor for late-onset Alzheimer's disease (AD), exacerbates tau tangles, amyloid plaques, neurodegeneration, and neuroinflammation-the pathologica Show more
Apolipoprotein E4 (APOE4), the strongest genetic risk factor for late-onset Alzheimer's disease (AD), exacerbates tau tangles, amyloid plaques, neurodegeneration, and neuroinflammation-the pathological hallmarks of AD. While astrocytes are the primary producers of APOE in the CNS, neurons increase APOE expression under stress and aging. Prior work established that neuronal APOE4 is essential for AD pathogenesis, but whether it is sufficient to drive disease remained unknown. We generated a PS19 tauopathy mouse model selectively expressing APOE4 in neurons. Neuronal APOE4 alone proved sufficient to promote pathological tau accumulation and propagation, neurodegeneration, and neuroinflammation to levels comparable to a tauopathy model with human APOE4 knocked-in globally. Single-nucleus RNA sequencing further revealed similar transcriptomic changes in neurons and glia of both models. Together, these findings demonstrate that neuronal APOE4 alone can initiate and propagate AD pathologies, underscoring its pivotal role in disease pathogenesis and its potential as a therapeutic target. Show less
📄 PDF DOI: 10.1101/2025.11.25.690488
APOE
Rongqing Li, Zikai Zhang, Xin Zhang +6 more · 2025 · BMC neurology · BioMed Central · added 2026-04-24
Symptom burden in primary brain tumor patients varies, emphasizing the need for comprehensive understanding to improve patient care. This study aims to identify distinct symptom clusters among brain t Show more
Symptom burden in primary brain tumor patients varies, emphasizing the need for comprehensive understanding to improve patient care. This study aims to identify distinct symptom clusters among brain tumor patients in Shanghai, China, using Latent Profile Analysis (LPA) to guide personalized diagnosis, treatment, and supportive care. A longitudinal study was conducted among 161 patients with primary brain tumors in Shanghai. Participants completed the MD Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) at three intervals: the day of admission (T1), three days after surgery (T2), and two weeks after surgery (T3). Latent Profile Analysis (LPA) was used to identify subgroups with unique symptom patterns. Six distinct subgroups were identified (entropy = 0.964), ranging from low-burden to persistently severe patterns. Subgroup membership was partially associated with age, tumor grade, and diagnosis. These subgroups were: transient postoperative burden group, stable symptom with cognitive emergence group, distress-predominant, low burden group, elderly-high grade, persistently severe group, nausea-dominant recovery group, and distress-plus-nausea, younger urban group. Our findings reveal substantial heterogeneity in perioperative symptom experiences among brain tumor patients. Identifying subgroups with high and persistent symptom burden may help clinicians target interventions such as enhanced education, proactive monitoring, rehabilitation, psychological support, and antiemetic management. This subgroup-based approach may improve quality of life, reduce morbidity, and guide precision supportive care in neuro-oncology. Show less
📄 PDF DOI: 10.1186/s12883-025-04595-6
LPA
Chong Li, Yunfei Xu, Jiale Jia +5 more · 2025 · Animals : an open access journal from MDPI · MDPI · added 2026-04-24
Despite the known impacts of weaning on animal health, the underlying molecular mechanisms remain unclear, particularly how psychological and nutritional stress differentially affect gut health and im Show more
Despite the known impacts of weaning on animal health, the underlying molecular mechanisms remain unclear, particularly how psychological and nutritional stress differentially affect gut health and immune function over time. This study hypothesized that early weaning exerts distinct short- and long-term effects on lamb stress physiology, immunity, and gut health, mediated by specific molecular pathways. Twelve pairs of full-sibling male Hu sheep lambs were assigned to control (CON) or early-weaned (EW) groups. Plasma stress/immune markers were dynamically monitored, and intestinal morphology, antioxidant capacity, apoptosis, and transcriptomic profiles were analyzed at 5 and 28 days post-weaning. Early weaning triggered transient psychological stress, elevating hypothalamic-pituitary-adrenal (HPA) axis hormones (cortisol, catecholamines) and inflammatory cytokines (TNF-α) within 1 day ( Show less
📄 PDF DOI: 10.3390/ani15142135
APOA4
Yuchao Feng, Shu Zhang, Decheng Suo +4 more · 2025 · NPJ science of food · Nature · added 2026-04-24
Based on the Caco-2 cell heat stress model, the study explored the heat stress preventive regulatory mechanisms of key polyphenol fractions in mung bean by metabolomics and transcriptomics association Show more
Based on the Caco-2 cell heat stress model, the study explored the heat stress preventive regulatory mechanisms of key polyphenol fractions in mung bean by metabolomics and transcriptomics association analysis. Results Mung bean polyphenol intervention before heat stress significantly reduced the elevated expression level of heat shock protein 70 (HSP70) caused by 39 °C temperature. At the metabolic level, mung bean polyphenols could play a role in heat stress regulation by alleviating oxidative stress damage. At the gene level, mung bean polyphenols showed regulation of cell proliferation, differentiation, and DNA damage, with DUSP6 and NEURL3 as key regulatory genes. The correlation analysis showed that nucleotide metabolism, and oxidative phosphorylation metabolism were the key pathways in the regulation of mung bean polyphenols by heat stress. Then mung bean polyphenols can exert heat stress preventive activity through the regulation of cellular oxidative damage and energy metabolism. This study provides a good idea for the research and development of dietary intervention products for heat stress. Show less
📄 PDF DOI: 10.1038/s41538-025-00522-8
DUSP6
Yang Zheng, Qiuxuan Li, Yuxiu Yang +4 more · 2025 · Journal of the American Heart Association · added 2026-04-24
Calcific aortic valve stenosis (CAVS) can lead to cardiac adverse outcomes; however, currently, no effective pharmacological interventions are available to prevent or delay disease progression. Emergi Show more
Calcific aortic valve stenosis (CAVS) can lead to cardiac adverse outcomes; however, currently, no effective pharmacological interventions are available to prevent or delay disease progression. Emerging evidence has identified significant associations between CAVS and key biomarkers, including Lp(a) (lipoprotein [a]), low-density lipoprotein cholesterol, and PCSK9 (proprotein convertase subtilisin/kexin type 9). However, robust evidence from randomized controlled trials is still lacking to substantiate these associations. The EPISODE (Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis) trial is a prospective, evaluator-blinded, randomized controlled trial designed to assess the therapeutic efficacy of PCSK9 inhibitors in patients with CAVS. A total of 160 patients with mild-to-moderate or asymptomatic severe CAVS will be randomly assigned to receive either statin monotherapy or a combination of statins and PCSK9 inhibitors. Participants will undergo follow-up assessments at 3-month intervals for 24 months, including transthoracic ultrasonic cardiogram, computed tomography, and quality-of-life evaluations using the EuroQol-5 Dimension-3 Level questionnaire. The primary end point is the annualized change in peak aortic jet velocity, whereas secondary end points encompass changes in aortic valve area, calcification score, incidence of heart valve surgery, and quality of life. Safety end points include all-cause mortality and cardiovascular events. The trial aims to evaluate the efficacy of PCSK9 inhibitors in modulating disease progression, reducing adverse cardiovascular events, and improving clinical outcomes in patients with CAVS. The anticipated findings are expected to provide critical insights for developing novel therapeutic strategies for early intervention in CAVS. URL: https://www.clinicaltrials.gov; Unique Identifier: NCT04968509. Show less
📄 PDF DOI: 10.1161/JAHA.125.042112
LPA
Qi He, Lin Jiang, Feng-Lei Chao +11 more · 2025 · Experimental neurology · Elsevier · added 2026-04-24
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (LINGO-1) is a neuronal system-specific transmembrane protein that is highly expressed in the brains o Show more
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (LINGO-1) is a neuronal system-specific transmembrane protein that is highly expressed in the brains of patients with Alzheimer's disease (AD), and our previous findings showed that LINGO-1 antagonism can improve cognitive function and protect hippocampal GABAergic interneurons in AD model mice. However, the specific mechanism underlying these effects is not clear. In this study, an adeno-associated virus (AAV) was used to directly interfere with hippocampal LINGO-1 in vivo, and LINGO-1 antagonists, cannabinoid type 1 receptor (CB1R) agonists, and CB1R antagonists were used to treat mouse hippocampal neurons (HT22 neurons) in vitro. We found that overexpressing hippocampal LINGO-1 in normal young mice impaired spatial learning and memory and reduced hippocampal CB1R protein levels, whereas silencing hippocampal LINGO-1 in AD model mice had the opposite effect. Additionally, antagonizing LINGO-1 increased CB1R/tyrosine kinase receptor B (TrkB) signalling and rescued CB1R- rich cholecystokinin-GABAergic (CCK-GABAergic) interneurons in HT22 neurons transduced with an APP/PS1-expressing virus. Competitive inhibition of LINGO-1 and CB1R was observed, and antagonizing LINGO-1 reversed the changes in HT22 neurons caused by the inhibition of CB1R, such as the decreases in the protein levels of doublecortin (DCX), TrkB, and phosphorylated TrkB (p-TrkB). These findings provide an important scientific basis for further exploration of the mechanism by which LINGO-1 regulates cognitive function and hippocampal GABAergic interneurons in AD model mice. Show less
no PDF DOI: 10.1016/j.expneurol.2025.115319
LINGO1
Wenxiu Wang, Rui Li, Zimin Song +4 more · 2025 · JAMA cardiology · added 2026-04-24
Despite substantial progress in low-density lipoprotein cholesterol (LDL-C)-lowering strategies, residual cardiovascular risk remains. Apolipoprotein C3 (APOC3) has emerged as a novel target for lower Show more
Despite substantial progress in low-density lipoprotein cholesterol (LDL-C)-lowering strategies, residual cardiovascular risk remains. Apolipoprotein C3 (APOC3) has emerged as a novel target for lowering triglycerides. Multiple clinical trials of small-interfering RNA therapeutics targeting APOC3 are currently underway. To investigate whether genetically predicted lower APOC3 is associated with a reduction in cardiovascular risk and if the combined exposure to APOC3 and LDL-C-lowering variants is associated with a reduction in the risk of coronary heart disease (CHD). This was a population-based genetic association study with 2 × 2 factorial mendelian randomization. Included were participants of European ancestry in the UK Biobank. Data were analyzed from November 2023 to July 2024. Genetic scores were constructed to mimic the effects of APOC3, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), and proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors. Plasma lipid and lipoprotein levels, CHD, and type 2 diabetes (T2D). This study included 401 548 UK Biobank participants (mean [SD] age, 56.9 [8.0] years; 216 901 female [54.0%]). Genetically predicted lower APOC3 was associated with a lower risk of CHD (odds ratio [OR], 0.96; 95% CI, 0.93-0.98) and T2D (0.97; 95% CI, 0.95-0.99). Genetically lower APOC3 and PCSK9 were associated with a similar magnitude of risk reduction in CHD per 10-mg/dL decrease in apolipoprotein B (ApoB) level (APOC3: 0.70; 95% CI, 0.59-0.83; PCSK9: 0.71; 95% CI, 0.65-0.77). Combined exposure to genetically lower APOC3 and PCSK9 was associated with an additive lower risk of CHD (APOC3: 0.96; 95% CI, 0.92-0.99; PCSK9: 0.93; 95% CI, 0.90-0.97; combined: 0.90; 95% CI, 0.86-0.93). Genetically lower HMGCR was also associated with a lower risk of CHD, and the risk was further reduced when combined with APOC3 (0.93; 95% CI, 0.90-0.97). Genetically predicted lower APOC3 was associated with a reduced risk of CHD that is comparable with that associated with lower PCSK9 per unit decrease in ApoB. Combined exposure to APOC3 and LDL-C-lowering variants was associated with an additive reduction in CHD risk. Future studies are warranted to investigate the therapeutic potential of these combined therapies, particularly among high-risk patients who cannot achieve therapeutic targets with existing lipid-lowering therapies. Show less
no PDF DOI: 10.1001/jamacardio.2025.0195
APOB
Chengxi Wu, Yaoyao Li, Yuting Liu +7 more · 2025 · International journal of nanomedicine · added 2026-04-24
In the microenvironment of atherosclerosis (AS), low-density lipoprotein (LDL) accumulates in injured endothelial areas and undergoes oxidation, thereby generating oxidized LDL (ox-LDL). The formation Show more
In the microenvironment of atherosclerosis (AS), low-density lipoprotein (LDL) accumulates in injured endothelial areas and undergoes oxidation, thereby generating oxidized LDL (ox-LDL). The formation of ox-LDL, in turn, not only amplifies endothelial cell (EC) dysfunction but also triggers macrophage polarization into the pro-inflammatory M1 phenotype. This cascade results in increased inflammatory cytokine secretion and exacerbated lipid accumulation. Therefore, a dual-targeting strategy aimed at both ECs and macrophages to inhibit the vicious circle between inflammation and lipids is a promising avenue for AS treatment. Simvastatin (SIM)-loaded nanomicelles (PLA-PEG/SIM) were prepared using the thin-film hydration method. Then, platelet membrane (PM) was coated the nanomicelles via sonication to obtain PM@PLA-PEG/SIM dual-targeting biomimetic nanoparticles. The morphological features of the nanoparticles were assessed by transmission electron microscopy (TEM). Cytotoxicity was evaluated using the CCK-8 assay and live/dead cell staining. Their targeting ability toward ECs and macrophages was assessed by flow cytometry and confocal laser scanning microscopy (CLSM). The biosafety, targeting ability, and therapeutic efficacy of PM@PLA-PEG/SIM against AS were further validated in ApoE PM@PLA-PEG/SIM effectively reduced the drug toxicity of SIM, exhibiting good biocompatibility. In vitro, cell experiment results showed that the nanoparticles inhibited foam cell formation, decreased interleukin-6 (IL-6) expression, and increased interleukin-4 (IL-4) and interleukin-10 (IL-10) expression by promoting macrophage repolarization. In vivo, results indicated that the formulation demonstrated excellent plaque-targeting ability. More importantly, the plaque area and lipid levels in the PM@PLA-PEG/SIM group were lowest, and plaques were most stable, showing its best therapeutic efficiency. PM@PLA-PEG/SIM alleviated progression of AS by co-targeting ECs and macrophages to inhibit the vicious cycle between inflammation and lipids. Our study provides a new strategy for the treatment of the disease by the co-targeting biomimetic nanoparticle. Show less
📄 PDF DOI: 10.2147/IJN.S558039
APOE
Xia Chen, Shengkun Zhang, Yujuan Qi +17 more · 2025 · Human molecular genetics · Oxford University Press · added 2026-04-24
Mesenchymal cells constitute the primary structural support elements within endometriotic lesions, yet their pivotal roles in endometriotic pathogenesis remain largely uncharted. This study aimed to c Show more
Mesenchymal cells constitute the primary structural support elements within endometriotic lesions, yet their pivotal roles in endometriotic pathogenesis remain largely uncharted. This study aimed to construct a single-cell atlas of endometriosis using samples from three ovarian tissues affected by endometriosis and three normal ovarian tissues. Through the utilization of scRNA-seq, we have unveiled six distinct mesenchymal subclusters in normal and endometriosis-afflicted ovaries, elucidating the diverse functions of mesenchymal populations in endometriosis. Our comprehensive analysis has revealed that mesenchymal cells predominantly engage in three key functions: ribosome-mediated protein synthesis and processing, cell adhesion facilitating intercellular support and communication, and a range of metabolic processes. Furthermore, our findings have identified several pivotal differentially expressed genes (e.g. C3, FN1, COL3A1, COL1A1, NRXN3), primarily associated with the complement and coagulation cascades, extracellular matrix (ECM) regulation, ECM receptor interactions, and cell adhesion molecules. In essence, our study provides a comprehensive transcriptomic dataset and novel insights into adhesive molecule and integrin networks within mesenchymal subclusters in endometriosis. This, in effect, has deepened the understanding of the pathomechanisms governing this condition. Show less
no PDF DOI: 10.1093/hmg/ddaf065
NRXN3
Wanglin Zhao, Xiyun Li, Haichao Gu +2 more · 2025 · Biochemical and biophysical research communications · Elsevier · added 2026-04-24
Osteoporotic bone defects pose significant clinical challenges. While icariin (ICA) exhibits pro-osteogenic effects in vitro, its capacity to repair osteoporosis (OP)-related bone defects remains unve Show more
Osteoporotic bone defects pose significant clinical challenges. While icariin (ICA) exhibits pro-osteogenic effects in vitro, its capacity to repair osteoporosis (OP)-related bone defects remains unverified. This study investigates ICA' s therapeutic role in bone regeneration and elucidates its molecular mechanisms via the Hippo pathway in bone marrow mesenchymal stem cells (BMSCs) and OP rats. Rat BMSCs were isolated and characterized by flow cytometry (CD29+/CD34-/CD45-). BMSCs were induced under osteogenic conditions with ICA at 25 and 50 mg/L. Osteogenic differentiation and mineralization were assessed by ALP and Alizarin Red staining and by measuring mRNA and protein levels of ALP, Runx2, and OCN. The Hippo/TAZ pathway was evaluated by Western blot and qPCR for MST1, p-MST1, TAZ, and p-TAZ. A rescue experiment employed the Hippo pathway agonist lysophosphatidic acid (LPA). An ovariectomized (OVX) rat model of osteoporosis was established to validate ICA's effects in vivo, examined by micro-CT, histology, and tibial expression analyses of osteogenic markers and Hippo/TAZ signaling components. ICA promoted osteogenic differentiation and mineralization of BMSCs. Mechanistically, ICA did not alter MST1 or TAZ transcripts but markedly reduced MST1 and TAZ phosphorylation, thereby stabilizing total TAZ and enhancing downstream osteogenesis. Co-treatment with LPA abrogated ICA-induced osteogenesis, confirming Hippo/TAZ pathway dependence. In OVX rats, ICA mitigated bone loss, improved trabecular microarchitecture (BMD, BV/TV, Tb.N), and upregulated tibial expression of ALP, Runx2, and OCN. Consistently, ICA reduced p-MST1 and p-TAZ levels and increased total TAZ in bone tissues. ICA promotes bone formation both in vitro and in vivo by inhibiting Hippo kinase activity and stabilizing TAZ, thereby enhancing osteogenic differentiation. Our findings identify the Hippo/TAZ axis as a potential therapeutic target for OP and support further translational exploration of ICA as an anti-osteoporotic agent. Show less
no PDF DOI: 10.1016/j.bbrc.2025.152888
LPA
Xiaokun Li, Zhiheng Rao, Wenhao Hu +2 more · 2025 · Obesity reviews : an official journal of the International Association for the Study of Obesity · Blackwell Publishing · added 2026-04-24
Metabolic dysfunction-associated steatohepatitis (MASH) is a condition characterized by hepatosteatosis, inflammation, and tissue damage, with steatosis as the initial stage, which involves chronic, e Show more
Metabolic dysfunction-associated steatohepatitis (MASH) is a condition characterized by hepatosteatosis, inflammation, and tissue damage, with steatosis as the initial stage, which involves chronic, excess deposition of lipids in hepatic lipid droplets. Despite the growing prevalence and serious risks it poses, including liver decompensation, the need for transplantation, and increased patient mortality, MASH currently faces no approved pharmacotherapy. Several promising treatment candidates have emerged from recent clinical trials, including analogs of FGF21 and agonists of the associated FGFR1-KLB complex. These agents were well-tolerated in trials and have demonstrated significant improvements in both histological and biochemical markers of liver fat content, inflammation, injury, and fibrosis in patients with MASH. Endocrine FGF21 plays a vital role in maintaining homeostasis of lipid, glucose, and energy metabolism. It achieves this through pathways that target lipids or lipid droplets in adipocytes and hepatocytes. Mechanistically, pharmacological FGF21 acts as a potent catabolic factor to promote lipid or lipid droplet lipolysis, fatty acid oxidation, mitochondrial catabolic flux, and heat-dissipating energy expenditure, leading to effective clearance of hepatic and systemic gluco-lipotoxicity and inflammatory stress, thereby preventing obesity, diabetes, and MASH pathologies. In this review, we aim to provide an update on the outcomes of clinical trials for several FGF21 mimetics. We compare these outcomes with preclinical studies and offer a lipid-centric perspective on the mechanisms underlying the clinical benefits of these agents for MASH. Show less
no PDF DOI: 10.1111/obr.13861
FGFR1
Shuo Yang, Jinfeng Li, Hongli Zeng +7 more · 2025 · Journal of medical biochemistry · added 2026-04-24
To explore the correlation between different traditional Chinese medicine (TCM) constitution types and apolipoprotein B (ApoB) in patients with hyperuricemia (HUA) and to investigate the relationships Show more
To explore the correlation between different traditional Chinese medicine (TCM) constitution types and apolipoprotein B (ApoB) in patients with hyperuricemia (HUA) and to investigate the relationships between TCM constitutions, uric acid levels, and various cardiovascular risk factors. A cross-sectional study involving 683 patients diagnosed with HUA was conducted. Patients' TCM constitutions were classified using the standardise "Classification and Determination of TCM Constitution" questionnaire. Serum uric acid (UA), lipid profiles, ApoB, and homocysteine (Hcy) levels were measured. Among 683 HUA patients, phlegm-dampness (22.99% ) and damp-heat constitution (20.06% ) were the most common TCM constitution types. UA, ApoB, and Hcy levels in patients with phlegm-damp constitution were significantly higher than those in other constitutions (P< 0.05). UA levels were negatively correlated with HDL-C (r=-0.472, P= 0.027) and positively correlated with ApoB (r= 0.618, P= 0.012) and Hcy (r= 0.492, P= 0.018). Phlegm-damp and damp-heat constitutions are the most common TCM constitution types in HUA patients and are associated with higher levels of UA, ApoB, and Hcy. These constitutional types are independently associated with increased cardiovascular risk. Show less
📄 PDF DOI: 10.5937/jomb0-57755
APOB
Tao Yang, Xiaohu Hu, Fei Cao +15 more · 2025 · Nature · Nature · added 2026-04-24
The mammalian gut harbours trillions of commensal bacteria that interact with their hosts through various bioactive molecules
📄 PDF DOI: 10.1038/s41586-025-08990-4
APOB
Bobo Yuan, Jianrui Li, Qing Shu +3 more · 2025 · The journal of headache and pain · BioMed Central · added 2026-04-24
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by hyperglycemia and insulin resistance, Migraine is a common chronic neurological disease caused by increased excitability of the Show more
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by hyperglycemia and insulin resistance, Migraine is a common chronic neurological disease caused by increased excitability of the central nervous system, both exerting substantial health burdens. However, the shared genetic basis and underlying molecular mechanisms remain largely unexplored. This study integrates single-cell data and Mendelian randomization (MR) analysis to identify comorbidity-associated genes and elucidate potential mechanistic links between these two conditions. Single-cell datasets from T2DM and migraine were analyzed to identify differentially expressed genes (DEGs). MR analysis was employed to prioritize key causal genes, followed by network-based functional characterization, disease-drug association analysis, cell annotation, and pseudo-time trajectory modeling. Analysis of single-cell data identified 2,128 migraine-associated and 3,833 T2DM-associated genes, with 714 genes shared between the two diseases. MR analysis highlighted AP4E1 and HSD17B12 as key regulators implicated in both conditions. Network analysis further linked these genes to lipid metabolism and vesicle transport pathways. Computational predictions revealed common comorbidities, including metabolic dysregulation and chemical-induced liver injury, as well as potential therapeutic agents such as valproic acid and bisphenol A. Single-cell annotation identified six major immune cell types in T2DM (T cells, NK cells, B cells, CD14 monocytes, CD16 monocytes, and dendritic cells), with T cells emerging as central players. In migraine, five immune cell types were identified (CD4 T cells, CD8 T cells, B cells, NK cells, and monocytes), with monocytes being the predominant cell type. Pseudo-time analysis delineated seven subpopulations of T cells and four subpopulations of monocytes, suggesting distinct functional trajectories in disease pathogenesis. However, due to the use of peripheral blood-derived single-cell data, genes primarily expressed in the central nervous system, such as CALCA and RAMP1, could not be detected, limiting the identification of certain migraine-specific pathways. This single-cell data and MR analysis investigation identifies AP4E1 and HSD17B12 as pivotal genetic determinants in T2DM-migraine comorbidity, shedding light on their molecular interplay and potential therapeutic relevance. Show less
📄 PDF DOI: 10.1186/s10194-025-02090-4
HSD17B12
Sijie Gu, Haoran Feng, Xiaomei Li +10 more · 2025 · Molecular therapy : the journal of the American Society of Gene Therapy · Elsevier · added 2026-04-24
Preventing the progression from acute kidney injury (AKI) to chronic kidney disease (CKD) remains a considerable clinical challenge. In this study, we elucidate the role of WNT5A in accelerating the A Show more
Preventing the progression from acute kidney injury (AKI) to chronic kidney disease (CKD) remains a considerable clinical challenge. In this study, we elucidate the role of WNT5A in accelerating the AKI-to-CKD transition and its underlying mechanisms. Renal biopsies from patients with AKI showed marked upregulation of WNT5A and its receptor, CD146, in proximal tubules, with higher expression in patients with CKD progression. In murine AKI models, Wnt5a knockdown attenuated CKD progression. Conversely, proximal tubular overexpression of Wnt5a exacerbated renal fibrosis in ischemia-reperfusion injury (IRI) mice, which was alleviated by Box5, a specific WNT5A antagonist. In vitro, WNT5A overexpression in transforming growth factor β (TGF-β)-stimulated HK-2 cells promoted CD146 upregulation, activated JNK phosphorylation, and enhanced SNAI1 expression. The genetic silencing of WNT5A/CD146 and JNK inhibition suppresses SNAI1 expression and attenuates fibrotic responses. Mechanistically, JNK-mediated c-JUN phosphorylation promoted its interaction with KLF5 at the SNAI1 promoter, driving renal fibrosis. Elevated serum levels of soluble CD146 correlated with renal function in patients with AKI and were higher in patients exhibiting CKD progression. Inhibition of WNT5A could serve as a therapeutic target for delaying renal fibrosis in AKI progression. Show less
no PDF DOI: 10.1016/j.ymthe.2025.06.039
SNAI1
Songfen Wu, Haicai Zhuang, Xidan Zhou +1 more · 2025 · Frontiers in behavioral neuroscience · Frontiers · added 2026-04-24
NRBF2, a component of autophagy-associated PIK3C3/VPS34-containing phosphatidylinositol 3-kinase complex, plays a crucial role in learning and memory processes, yet its specific impact on memory and t Show more
NRBF2, a component of autophagy-associated PIK3C3/VPS34-containing phosphatidylinositol 3-kinase complex, plays a crucial role in learning and memory processes, yet its specific impact on memory and the underlying molecular mechanisms remains unclear. Here, we utilized NRBF2 knockout mice to examine its influence on the time course of fear memory. Employing quantitative PCR, Western blot analysis, behavioral tests, and electrophysiology, we investigated the mechanisms through which NRBF2 affects memory processing. We observed an increase in This study offer new insights into the role of NRBF2 and highlight the potential of targeting NRBF2 as a therapeutic strategy for addressing cognitive deficits associated with various disorders. Show less
no PDF DOI: 10.3389/fnbeh.2025.1529522
PIK3C3
Yuemei Zhang, Yuxin Cao, Yongxin Sun +12 more · 2025 · Proceedings of the National Academy of Sciences of the United States of America · National Academy of Sciences · added 2026-04-24
The activation of blood monocytes and the infiltration of monocyte-derived macrophages into the vessel walls are the central part of atherosclerosis. However, the mechanisms underlying the processes r Show more
The activation of blood monocytes and the infiltration of monocyte-derived macrophages into the vessel walls are the central part of atherosclerosis. However, the mechanisms underlying the processes remain unclear. Here, we report that G-protein signaling modulator 1 (GPSM1) plays a critical role in atherogenesis. We found that GPSM1 expression in lesional macrophages was increased during atherosclerosis development both in mice and humans. Myeloid-specific GPSM1 ablation protects mice against atherosclerosis and reduces aortic inflammation in both Show less
no PDF DOI: 10.1073/pnas.2517531122
APOE
Hong Tan, Li Li, YiPei Zhang +1 more · 2025 · Journal of multidisciplinary healthcare · added 2026-04-24
To identify distinct sleep quality profiles among patients undergoing maintenance hemodialysis (MHD) using latent profile analysis (LPA), and examine differences in perceived stigma across these sleep Show more
To identify distinct sleep quality profiles among patients undergoing maintenance hemodialysis (MHD) using latent profile analysis (LPA), and examine differences in perceived stigma across these sleep quality subtypes. From December 2024 to March 2025, a total of 334 MHD patients were recruited via convenience sampling from the nephrology departments of two tertiary hospitals in Xinjiang, China. Data were collected using structured questionnaires, including the Pittsburgh Sleep Quality Index (PSQI), the Self-Rating Depression Scale (SDS), and the Social Impact Scale (SIS), along with sociodemographic and clinical information. LPA was employed to identify latent subgroups of sleep quality based on PSQI components. Multinomial logistic regression was used to determine predictors of sleep profile membership. Differences in stigma scores across sleep profiles were analyzed using non-parametric equivalents. Three distinct sleep profiles were identified: Class 1 - "overall better sleep", Class 2 - "short sleep duration and low efficiency", and Class 3 - "poor sleep quality with high medication use". Multinomial logistic regression identified comorbid heart failure (OR=2.867, Patients with MHD exhibit heterogeneous patterns of sleep disturbance, which are associated with varying levels of perceived stigma. Those with the poorest sleep quality and highest reliance on medication experience the most pronounced stigma. Tailored interventions addressing sleep-related issues and psychosocial factors may help reduce stigma and improve patient well-being. Show less
📄 PDF DOI: 10.2147/JMDH.S557424
LPA